News

At the J.P. Morgan Healthcare Conference earlier this month, the discussion from Echo Health Ventures focused on the basics of diligence, investments, and ROI payback

Echo Health Ventures co-hosted a panel during New England Venture Capital Association’s (NEVCA) Health Week to discuss health care sales cycles.

For startups, there has never been more opportunity, nor has there been more high-stake complexity in navigating the next phase managing and sharing health care data.

Telemedicine can improve access to heart care, said Jeff Wessler, MD, Founder and CEO of Heartbeat Health, on a new podcast with Oliver Wyman’s Ann Kaplan.

Medix Infusion, which creates access to infusion therapy for patients in rural, suburban and other underserved markets, has closed a $35 million Series B funding round led by Echo Health Ventures.

GNS, the leader in the application of causal AI and “Digital Twins” to discover and develop new drugs, announced its rebranding as Aitia.

Global Corporate Venturing this week honored two members of the Echo Health Ventures Strategic Investment team: Echo Partner Kurt Sheline and Echo Principal Omair Ahmed.

We are happy to announce that Maura Little, Managing Principal at Echo Health Advisors, has been appointed by Washington Gov. Jay Inslee to the board of directors of the Andy Hill Cancer Research Endowment (CARE) Fund.

The Portland Business Journal wrote this week about Echo Health Ventures’ unique investment model and how Echo builds and grows its portfolio companies and drives innovative health care solutions for its four member health plans.